SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about outcome of board meeting

21 Jan 2026 Evaluate
Zim Laboratories has informed that the Board of Directors (Board) of the ZIM Laboratories (Company) at its meeting held today, 21st January, 2026, has, considered and approved the following matters: Issue and allotment of equity shares of the Company by way of a preferential issue on a private placement basis; and Convening an extra-ordinary general meeting of the Company and related matters.

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

71.75 -1.32 (-1.81%)
13-Apr-2026 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1647.95
Dr. Reddys Lab 1215.90
Cipla 1213.25
Zydus Lifesciences 911.00
Lupin 2320.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×